OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.
Published in:
World Journal of Urology, 2022, v. 40, n. 10, p. 2459, doi. 10.1007/s00345-022-04108-x
By:
- Angulo, J. C.;
- Ciria Santos, J. P.;
- Gómez-Caamaño, A.;
- Poza de Celis, R.;
- González Sala, J. L.;
- García Garzón, J. M.;
- Galán-Llopis, J. A.;
- Pérez Sampietro, M.;
- Perrot, V.;
- Planas Morin, J.;
- on behalf of ANARESISTANCE study group;
- Abascal, José Manuel;
- Barrond, Víctor;
- Benedicto, Antonio;
- Carballo, Ana;
- Cortiñas, José Ramón;
- Fernández, Manuel;
- Ferrer, Eduardo;
- Guzmán, Pablo Luís;
- López, Miguel Ángel
Publication type:
Article
Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy.
Published in:
Rheumatology International, 2014, v. 34, n. 10, p. 1419, doi. 10.1007/s00296-014-2977-3
By:
- Planas Morin, J.;
- Celma Domenech, A.;
- Placer Santos, J.;
- Trilla Herrera, E.;
- Salvador Lacambra, C.;
- Lorente Garcia, D.;
- Regis, L.;
- Carles Galceran, J.;
- Morote Robles, J.
Publication type:
Article